Intelligence Platform
Patents
Browse 124 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6444668
Combination regimens using progesterone receptor modulators
expired patentUS 6441019
Cyclocarbamate and cyclic amide derivatives
expired patentUS 6436929
Cyclothiocarbamate derivatives as progesterone receptor modulators
expired patentUS 6423699
Combination therapies using benzimidazolones
expired patentUS 6417214
3,3-substituted indoline derivatives
expired patentUS 6417212
Modulators of peroxisome proliferator activated receptors
expired patentUS 6413952
Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating meta
expired patentUS 6407101
Cyanopyrroles
expired patentUS 6399593
Cyclic regimens using cyclic urea and cyclic amide derivatives
expired patentUS 6391907
Indoline derivatives
expired patentUS 6380207
Glucocortiocoid-selective antiinflammatory agents
expired patentUS 6380235
Benzimidazolones and analogues
expired patentUS 6380178
Cyclic regimens using cyclocarbamate and cyclic amide derivatives
expired patentUS 6369056
Cyclic urea and cyclic amide derivatives
expired patentUS 6358948
Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
expired patentUS 6358947
Tetracyclic progesterone receptor modulator compounds and methods
expired patentUS 6355648
Thio-oxindole derivatives
expired patentUS 6339098
2,1-benzisothiazoline 2,2-dioxides
expired patentUS 6329416
Combination regimens using 3,3-substituted indoline derivatives
expired patentUS 6320074
Compounds having selective activity for retinoid X receptors, and means for modulation of
expired patentUS 6319912
Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
expired patentUS 6316404
Treating NIDDM with RXR agonists
expired patentUS 6306851
Cyclocarbamate and cyclic amide derivatives
expired patentUS 6228862
Treating NIDDM with RXR agonists
expired